Current thoughts on angiogenesis.
Research into the distinct phases of the process of angiogenesis has informed the development of growth factor therapy and tissue-engineered products, but more studies are needed to ensure the development of new therapeutic strategies.
Chan
L K W
LK
Department of Plastic Surgery, St John's Hospital, Livingston, UK. lennard.chan@nhs.net
D043925:Angiogenesis Inducing Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D015687:Cell Hypoxia / Q000187:drug effects / Q000502:physiology; D002986:Clinical Trials as Topic; D004353:Drug Evaluation, Preclinical; D005346:Fibroblast Growth Factors / Q000627:therapeutic use; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000494:pharmacology / Q000627:therapeutic use*; D018919:Neovascularization, Physiologic / Q000187:drug effects / Q000502:physiology; D010982:Platelet-Derived Growth Factor / Q000627:therapeutic use; D013673:Technology Assessment, Biomedical; D023822:Tissue Engineering / Q000379:methods; D042461:Vascular Endothelial Growth Factor A / Q000627:therapeutic use; D014945:Wound Healing / Q000187:drug effects / Q000502:physiology; D014947:Wounds and Injuries / Q000188:drug therapy
D043925:Angiogenesis Inducing Agents; D036341:Intercellular Signaling Peptides and Proteins; D010982:Platelet-Derived Growth Factor; D042461:Vascular Endothelial Growth Factor A; D005346:Fibroblast Growth Factors